Young Alport Syndrome Patients Can Apply for Paul Silver Tribute Award Envelope icon Subscribe to our newsletter Get regular updates to your inbox. Your Email Subscribe Leave this field empty if you're human: Skip to content Toggle navigation Home About Alport Syndrome Toggle menu What Is Alport Syndrome? Types Causes Symptoms Diagnosis Living With Alport Syndrome Treatments Toggle menu Approved Treatments Experimental Treatments Non-drug Treatments News Search Close drawer What can we help you find today? Search for: Search Search Search for: Search News Young People with Alport Syndrome Can Apply for Life-enriching Paul Silver Tribute Award Young People with Alport Syndrome Can Apply for Life-enriching Paul Silver Tribute Award by Charles Moore | August 23, 2017 Share this article: Share article via email Copy article link The Alport Syndrome Foundation is inviting young people with the disease to apply for an award that allows them to pursue an activity or complete a project. November 3 is the deadline for applying for the 2018 Paul Silver Tribute Award, which is aimed at enriching the lives of Alport patients aged 16 to 22. Alport syndrome is a hereditary kidney disease that doctors often fail to diagnose or misdiagnose. Most men who develop it experience kidney failure by the time they reach their 20s. It also causes hearing loss, and vision problems. The Alport Syndrome Foundation estimates that 30,000 to 60,000 Americans have the disease. Although no treatment can prevent the kidney failure that it leads to, the foundation said early diagnosis is essential because medications are available that can slow its progression. The $3,000 Silver award honors a Hollywood film and music editor who died of Alport syndrome at the age of 38 in 2004. Silver received a similar award in 1985 while studying film-making in college. It enabled him to buy a camera and other equipment to make a documentary film about a trip he made to the Tuscany region of Italy to attend a summer study program. The award can be used for a range of activities, such as taking music lessons, attending a summer camp, taking an educational trip, or working on a project. “We are in our sixth year of accepting applications for this award,” Sharon Lagas, the president of the Alport Syndrome Foundation board, said in a press release. “Thirteen young people with Alport syndrome have already received this award.” Their stories are “inspirational, full of courage and provide positive role models for other young people affected by this disease,” Lagas said. The judges can decide to award that entire $3,000 to one person, or split it between two or more people. Applicants must write an essay no longer than three pages that addresses the questions: • How has Alport syndrome affected you? • What are your extracurricular activities, hobbies and interests? • Why do you want to receive the award? • How will you use the award? • How will it enhance your life or education? The main things that judges will consider in weighing applications is the reason an applicant wants an award, the potential impact it will have on them, the quality of their essay, and the completeness of their submission. You can download an application here. You can find previous winners’ essays on the foundation website. Print This Page About the Author Charles Moore Charles is a force to be reckoned with in the world of print and new media. From an interview with him in LowEndMac: ”His articles, features, and commentaries have appeared in more than 40 magazines, newspapers and websites in Canada, the US, the UK, and Australia. . . a columnist for The Halifax Daily News and the Saint John Telegraph Journal, Atlantic Fisherman, and news editor and columnist for Applelinks.com, a columnist and contributing editor for MacOpinion and PBCentral, as well as writing for Low End Mac.” Tags Alport Syndrome Foundation, Applications, Paul Silver Tribute Award Comments Leave a comment Fill in the required fields to post. Your email address will not be published. Your Name Your Email Your Comment Post Comment Create your own user feedback survey Recent Posts New Mouse Model With Slower Alport Progression May Lead to Better Understanding, Study Says Chinook Acquires Global Rights to Develop Atrasentan for Alport, Other Kidney Diseases Gene Therapy Repairs Mutations in Kidney Cells from Alport Patients, Study Shows US Kidney Disease Data Points to Need for Early Detection and Better Awareness, AKF Says Reata and Invitae Partner to Offer Genetic Testing and Counseling for Chronic Kidney Disease Recommended reading January 13, 2020 News by Ana Pena, PhD Chinook Acquires Global Rights to Develop Atrasentan for Alport, Other Kidney Diseases January 6, 2020 News by Marta Figueiredo Gene Therapy Repairs Mutations in Kidney Cells from Alport Patients, Study Shows December 16, 2019 News by Mary Chapman US Kidney Disease Data Points to Need for Early Detection and Better Awareness, AKF Says Envelope icon Subscribe to our newsletter Get regular updates to your inbox. Your Email Subscribe Leave this field empty if you're human: BioNews Services, LLC 3 W Garden St Suite 700 Pensacola, FL 32502 Website: bionews.com Email: [email protected] Phone: 1-800-936-1363 Publishing Team Leadership Our Culture Corrections Policy Careers Contact Us Terms of Service Privacy Policy Disable Notifications Advertising Policy Disclaimer This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Copyright © 2013-2022 All rights reserved.